Timing of Antiretroviral Therapy Initiation and Risk of Cancer Among Persons Living With Human Immunodeficiency Virus.

Michael J SilverbergWendy LeydenRaúl U Hernández-RamírezLi QinHaiqun LinAmy C JusticeNancy A HessolChad J AchenbachGypsyamber D'SouzaEric A EngelsKeri N AlthoffAngel M MayorTimothy R SterlingMari M KitahataRonald J BoschMichael S SaagCharles S RabkinMichael A HorbergM John GillSurbhi GroverW Christopher MathewsJun LiHeidi M CraneStephen J GangeBryan LauRichard D MooreRobert DubrowRomain S Neugebauer

Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2021)

Earlier ART initiation has potential to reduce the burden of virus-related cancers in PLWH but not non-AIDS-defining cancers (NADCs) without known or suspected viral etiology.

Keyphrases

antiretroviral therapy
human immunodeficiency virus
hiv infected
hiv infected patients
hiv positive
hiv aids
papillary thyroid
childhood cancer
sars cov
squamous cell
pulmonary embolism
risk factors
human health
squamous cell carcinoma
risk assessment
climate change
south africa
hiv testing
drug induced